The stock market is on edge as stimulus talks continue to be gridlocked. Today on Dumb Money, we'll tell you what we're expecting and how we are investing our money.

Amazon is now in the pharmacy business with online prescription drugs, free deliveries, and "massive discounts" for Prime members when they pay without insurance. Today on Dumb Money, our go-to med-tech expert, Dr. Chase Feiger, reveals his big stock trade and what Amazon Pharmacy means for GoodRx and traditional in-store pharmacies like CVS, Walgreens, and Rite Aid.

The U.S. House of Representatives approved a bill decriminalizing marijuana at the federal level on Friday. Branded as the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, the bill removes cannabis from the list of federally controlled substances and facilitates canceling low-level federal convictions and arrests related to marijuana. While the legislation is not expected to pass in the Republican-controlled Senate, this is the first time Congress has acted on the issue and brings even more attention to the runoff races in Georgia that will determine the majority in January.

This trend is Ho Ho Hot! We found a stock we think might be a big winner this holiday season.

Today's guest thinks the global boom in anime's popularity is best monetized through mobile gaming and that China's bilibili is best positioned to capture China's mobile-first youth as they engage in generational anime trends.

Has Wall Street ignored the highly anticipated release of Cyberpunk 2077 and the potential impact for its publisher CD Projekt?

Nikola shares dropped more than 20% after GM gave up their equity stake and restructured a smaller reworked with Nikola. Even after the drop, we doubled down. Today we tell you why.

Making our list, checking it twice.

The Georgia runoff election for both U.S. Senate seats on Jan. 5, will determine which party controls the Senate. Some political analysts have estimated that $1 BILLION  dollars will be spent on political advertising. Today on Dumb Money, we reveal the stock that we think could be a big winner.

Investors are looking to cash in on what could be a brand new industry, competing against the traditional "big pharma" drugs used for mental health. These investors are speculating that new drug treatments will become legalized and commercialized. Maybe even as quickly as cannabis. As investors, we're always looking for the next big thing. Today on Dumb Money, the "Psychadelic Stocks" are we're buying in anticipation of what could be: an unprecedented SHROOM BOOM.